1492 Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–25–1046] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘National 

Breast and Cervical Cancer Early 

Detection Program (NBCCEDP) 

Monitoring Activities’’ to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on October 1, 

2024 to obtain comments from the 

public and affected agencies. CDC 

received five non-substantive comments 

related to the previous notice. This 

notice serves to allow an additional 30 

days for public and affected agency 

comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP) 

Monitoring Activities (OMB Control No. 

0920–1046, Exp. 3/31/2025)— 

Revision—National Center for Chronic 

Disease Prevention and Health 

Promotion (NCCDPHP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

CDC is requesting a Revision of the 

information collection (OMB Control 

No. 0920–1046), titled National Breast 

and Cervical Cancer Early Detection 

Program (NBCCEDP) Monitoring 

Activities. Information collection 

consists of an annual NBCCEDP survey, 

baseline and annual clinic-level data 

collection, a quarterly program update 

(QPU) tool, a service delivery projection 

worksheet, and minimum data elements 

(MDEs). CDC proposes revisions to the 

Annual NBCCEDP Survey, clinic-level 

data collection tool and quarterly 

program update (QPU), and continued 

use of the service delivery projection 

worksheet and MDEs with no changes. 

The number of respondents will 

increase from 70 to 71 and the total 

estimated annualized burden will 

decrease from 1,220 hours to 1,162 

hours. 

Breast and cervical cancers are 

prevalent among U.S. women. Evidence 

shows that deaths from both breast and 

cervical cancers can be avoided by 

increasing screening services— 

mammography, pap, and human 

papillomavirus (HPV) tests—among 

women. However, screening is typically 

underutilized among women who are 

under- or uninsured, have no regular 

source of healthcare, or who recently 

immigrated to the U.S. 

To improve access to cancer 

screening, Congress passed the Breast 

and Cervical Cancer Mortality 

Prevention Act of 1990 (Pub. L. 106– 

354), which directed CDC to create the 

National Breast and Cervical Cancer 

Early Detection Program (NBCCEDP). 

The NBCCEDP currently provides 

funding to 71 recipients under ‘‘Cancer 

Prevention and Control Programs for 

State, Territorial, and Tribal 

Organizations (DP22–2202).’’ The 

purpose of NBCCEDP is to increase 

breast and cervical cancer screening 

rates among women residing within 

defined geographical locations (as 

determined by the funded program) who 

are at or below 250% of the federal 

poverty level; aged 50–75 years for 

breast cancer services, and aged 21–64 

years for cervical cancer services; and 

are runder- or uninsured. 

CDC proposes revisions to three of the 

five information collections: 

• Annual NBCCEDP Survey— 

submitted to CDC annually and collects 

program-level information to monitor 

recipients’ challenges, external funding 

sources, partnerships, and EBI 

implementation. The survey has been 

revised to add questions related to 

partnership activities and recipients’ 

requirements for patients’ payments 

towards screening services, and remove 

COVID–19-related questions. 

• Clinic-level data collection— 

submitted to CDC at baseline and 

annually to assess health system, clinic, 

and patient population characteristics; 

monitoring and quality improvement 

activities; EBI implementation; and 

baseline or annual screening rates. The 

tool has been revised to remove COVID– 

19-related variables and update 

response options for measures used to 

report breast and cervical cancer 

screening rates. 

• QPU—submitted to CDC four times 

per year to monitor award spending, 

service delivery, staff vacancies, 

program challenges and successes, and 

technical assistance (TA) needs. This 

instrument has been revised to include 

two optional open-ended items for 

recipients to provide context to reported 

service delivery and spending data if 

needed. 

CDC proposes continued use of the 

remaining two information collections— 

the Service Delivery Project Worksheet 

and the MDEs—which have not been 

changed. 

To maximize consistency in our 

routine data collections for the current 

NBCCEDP funding cycle, CDC has not 

revised NBCCEDP information 

collections to align with the Department 

of Health and Human Services (HHS)’ 

current best practices for demographic 

questions related to sexual orientation 

and gender identity (SOGI) and race and 

ethnicity (R/E) at this time. However, 

CDC plans to revise information 

collections that include demographic 

items to align with HHS’ SOGI and R/ 

E guidelines for the next funding cycle 

beginning in 2027. The proposed 

modifications to the information 

collections will allow CDC to better 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 90, No. 5 / Wednesday, January 8, 2025 / Notices 1493 

gauge progress in meeting NBCCEDP 

program goals and monitor 

implementation activities, evaluate 

outcomes, and identify awardee 

technical assistance needs. In addition, 

findings will inform program 

improvement and help identify 

successful activities that need to be 

maintained, replicated, or expanded. 

CDC requests OMB approval for three 

years and for an estimated 1,162 annual 

burden hours. Participation is required 

for NBCCEDP awardees. There are no 

costs to respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs) 

NBCCEDP Recipients ..................................... Annual NBCCEDP Survey ............................. 71 1 46/60 

NBCCEDP Clinic-level Information Collection 

Instrument—Breast.

71 6 40/60 

NBCCEDP Clinic-level Information Collection 

Instrument—Cervical.

71 6 40/60 

Quarterly Program Update ............................. 71 4 32/60 

Service Delivery Projection Worksheet .......... 71 1 29/60 

MDEs .............................................................. 71 2 150/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Public Health Ethics and 

Regulations, Office of Science, Centers for 

Disease Control and Prevention. 

[FR Doc. 2025–00161 Filed 1–7–25; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–25–25CH; Docket No. CDC–2024– 

0102] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on a proposed information 

collection project titled Combating 

Antimicrobial Resistant Gonorrhea and 

Other STIs (CARGOS). CARGOS is a 

comprehensive strategy designed to 

streamline and improve the 

coordination of Antimicrobial 

Resistance (AR) surveillance and 

preparedness and response activities 

focused on Neisseria gonorrhoeae (GC) 

and expand capacity to include other 

STIs with emerging AR in the United 

States. 

DATES: CDC must receive written 

comments on or before March 10, 2025. 

ADDRESSES: You may submit comments 

identified by Docket No. CDC–2024– 

0102 by either of the following methods: 

b Federal eRulemaking Portal: 

www.regulations.gov. Follow the 

instructions for submitting comments. 

b Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

www.regulations.gov. Please note: 

Submit all comments through the 

Federal eRulemaking portal 

(www.regulations.gov) or by U.S. mail to 

the address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; 

Telephone: 404–639–7118; Email: omb@

cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of the existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of collecting 

information on those to respond, 

including using appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic responses; 

and 

5. Assess information collection costs. 

Proposed Project 

Combating Antimicrobial Resistant 

Gonorrhea and Other STIs (CARGOS)— 

New—National Center for HIV, Viral 

Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The purpose of the proposed 

Combating Antimicrobial Resistant 


lotter on DSK11XQN23PROD with NOTICES1